Chair
Board member since
2021
Nationality
Danish
Born
1963
Independent
Board committees, LEO Pharma
Chair of the Remuneration and Nomination Committee.
Positions and management duties
Member of the Advisory Board of VækstPartner Kapital ApS. Executive director of JBR Counselling A/S, Amanda K. B. Holding ApS, APKB Holding ApS and JBR Counselling Holding ApS and board member of JBR Counselling A/S.
Career
Former EVP Biopharm & Legal Affairs, CFO & EVP Finance, Legal & IR and SVP Corporate Finance at Novo Nordisk A/S. Former chair of SimCorp A/S, vice chair at William Demant Invest A/S, Novonesis A/S and Chr. Hansen Holding A/S, and board member at William Demant Fonden.
Special competencies
Extensive executive and board experience in global pharma companies, combining finance, legal, strategy and innovation leadership. Led major transformations, risk management, M&A transactions and global finance projects at Novo Nordisk A/S, oversaw the listings of Novozymes A/S (today Novonesis A/S) and NNIT A/S while at Novo Nordisk A/S, and steered strategic governance initiatives as chair of SimCorp A/S.
Meet our Board of Directors
The Board of Directors is accountable for LEO Pharma’s corporate governance, strategic direction, and long-term sustainability.
